Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12620001098921
ACTRN12620001098921
Not yet recruiting
未知

Prospective, Multi-centre Study to Assess Efficacy (Survivorship) of the Mpact 3D Metal MonoCer Cup Implant in Primary Total Hip Replacement

Medacta Australia Pty Ltd0 sites280 target enrollmentOctober 21, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHip OsteoarthritisMusculoskeletal - Osteoarthritis

Overview

Phase
未知
Intervention
Not specified
Conditions
Hip Osteoarthritis
Sponsor
Medacta Australia Pty Ltd
Enrollment
280
Status
Not yet recruiting
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 21, 2020
End Date
TBD
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Patients undergoing a primary total conventional hip replacement and are suitable for a cementless acetabular cup according to the indications for use (On\-label use).
  • •\- Use of the non TGA approved (pre\-market) Medacta Mpact 3D Metal MonoCer acetabular cup prosthesis.
  • •\- Adults aged between 18 and 75 years at the time of registration.
  • •\- Ability to give informed consent.
  • •\- Patients who are informed of the conditions of the study and are willing to participate for the length of the prescribed follow\-up period.

Exclusion Criteria

  • •\- Rheumatoid arthritis.
  • •\- Patients with a history of active infection.
  • •\- Any case not described in the inclusion criteria.
  • •\- Revision procedures.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
Multi-center study to evaluate the efficacy and to standardize RFA for early breast cancerEarly breast cancer
JPRN-UMIN000008675ational Cancer Center Hospital372
Not yet recruiting
Not Applicable
A multicenter clinical study to test the efficacy and safety of C1-inhibitor concentrate for clinical amniotic fluid embolism.clinical amnitotic fluid embolism
JPRN-UMIN000012273Department of Obstetrics and Gynecology, Mie university hospital.5
Completed
Not Applicable
Investigating the effect and safety of the Satisphere™ insert in overweight patients
ISRCTN81340421Endosphere Inc (USA)60
Completed
Not Applicable
Prospective multicenter trial to assess the effectiveness and safety of pulse methylprednisolone combined with intravenous immunoglobulin (IVIG) as a primary treatment in patients with acute Kawasaki DiseaseAcute Kawasaki Disease
JPRN-UMIN000009946the Osaka Kawasaki Dieaase Study Group418
Recruiting
Not Applicable
A Multicenter Prospective Study on the Efficacy of Small Intestinal Capsule Endoscopy in Hemodialysis Patients
JPRN-UMIN000041904Keio university school of medicine500